Press Release

March 8, 2019

Generation Bio to Present at the Cowen & Company 39th Annual Health Care Conference

CAMBRIDGE, Mass., March 8, 2019

Generation Bio, a company developing the first genetic medicines that can be re-dosed and titrated to effect for a lifetime of benefit, today announced that Geoff McDonough, President and Chief Executive Officer, will present at the Cowen & Company 39th Annual Health Care Conference on Tuesday, March 12, 2019 at 12:30 p.m. EST in Boston, MA.

To access a live webcast and subsequent archived recording of the presentation, please visit the “News” section on the Generation Bio website at www.generationbio.com/news/

 

About Generation Bio

Generation Bio is a biotechnology company developing a breakthrough class of genetic medicines to enable a new generation of people to live unaffected by inherited disease. The company is using its proprietary ceDNA platform to create gene therapies with drug-like properties – delivering durable gene expression with the ability to re-dose for individual patient titration and for the potential to sustain effect over a lifetime. Generation Bio was founded and launched by Atlas Venture and is headquartered in Cambridge, Mass. For more information, please visit www.generationbio.com or follow @generationbio.

Investors
Lauren Stival and Naina Zaman
Stern Investor Relations
(212) 362-1200
generationbio@sternir.com

Media
Max Stendahl
Ten Bridge Communications
(508) 277-8117
max@tenbridgecommunications.com

Take a seat at the table.

We are always looking for those who are ready to share their vision, talent, and tenacity—who believe in our mission and themselves.

Imagine a world without genetic disease.

What do you see? More health? Fewer doctor appointments? More bike riding? More peanut butter and jelly sandwiches? More life?
See our shared vision.
cross